ALLMedicine™ Breast Biopsy Center
Research & Reviews 456 results
https://doi.org/10.1016/j.ultrasmedbio.2022.03.009
Ultrasound in Medicine & Biology; Ng SY, Lin CL
May 10th, 2022 - Anthropomorphic phantoms have been used to provide residents with training in ultrasound-guided breast biopsy. However, different individuals differ in terms of the acoustic properties and stiffness of their breast tissues. The individual differen...
https://doi.org/10.1007/s11548-022-02640-0 10.3322/caac.21660 10.1002/cncr.32887 10.1016/j.crad.2018.05.029 10.1148/radiol.2017170180 10.1007/s40336-019-00319-2 10.1243/09544119jeim468 10.1109/LRA.2017.2678542 10.1016/j.mric.2017.12.010 10.1109/TRA.2003.817058 10.1002/rcs.1760 10.1007/s11548-017-1528-2 10.1109/mra.2017.2680541 10.1109/tbme.2017.2697766 10.1016/j.medengphy.2014.06.007 10.1002/cmr.b.20070 10.1002/rcs.2063 10.1007/s11548-017-1632-3 10.1109/TPAMI.1987.4767965 10.1007/BF02163027 10.1016/j.crad.2010.01.008 10.1016/j.jbiomech.2014.08.007 10.1002/jmri.21831
International Journal of Computer Assisted Radiology and ... Song C, Yang Z et. al.
May 1st, 2022 - Breast cancer is currently the cancer type with the highest incidence in the world, and it is extremely harmful to women's health. MRI-guided breast biopsy is a common method in clinical examination of breast cancer. However, traditional breast bi...
https://clinicaltrials.gov/ct2/show/NCT05343975
Apr 25th, 2022 - audio-guided meditation during breast biopsy procedures questionnaires (STAI-ETAT and EN) before and after the procedure.
https://doi.org/10.1177/00031348221082276
The American Surgeon; Jee Y, Bakht A et. al.
Apr 15th, 2022 - The recommendation for management of intraductal papilloma has not been clearly established and its surgical excision criteria remain controversial. This study determines the institutional malignancy upstage rate of benign intraductal papillomas a...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090689
Breast Cancer Research and Treatment; Pomerantz A, Tsoref D et. al.
Apr 9th, 2022 - To evaluate the total biopsy and positive biopsy rates in women at high risk of breast cancer compared to the general population. The study group consisted of 330 women with pathogenic variants (PVs) in BRCA1/2 attending the dedicated multidiscipl...
Drugs 29 results see all →
Clinicaltrials.gov 32 results
https://clinicaltrials.gov/ct2/show/NCT05343975
Apr 25th, 2022 - audio-guided meditation during breast biopsy procedures questionnaires (STAI-ETAT and EN) before and after the procedure.
https://clinicaltrials.gov/ct2/show/NCT02239874
Apr 7th, 2022 - Mammographic density is one of the strongest risk factors for breast cancer. It is predictive of breast cancer risk for at least 10 years in the futue and has been suggested as a surrogate marker of breast cancer risk. Several states now mandate r...
https://clinicaltrials.gov/ct2/show/NCT03544268
Apr 1st, 2022 - Increasing the sensitivity and specificity of diagnostic imaging in patients at high risk for breast cancer could provide substantial clinical benefit by improving diagnosis, preventing over-treatment, and reducing healthcare costs. Acoustic angio...
https://clinicaltrials.gov/ct2/show/NCT05062174
Feb 2nd, 2022 - This is a single arm, prospective, observational trial enrolling up to 10 patients within Indiana University Simon Comprehensive Cancer Center. Eligible women will be consented to undergo breast biopsy 2-6 days prior to prophylactic mastectomy and...
https://clinicaltrials.gov/ct2/show/NCT04886531
Jan 12th, 2022 - Patient will be treated with neratinib, an aromatase inhibitor and trastuzumab for 24 weeks prior to surgery, following an initial 3 weeks of neratinib alone, aromatase inhibitor alone or the combination of neratinib and an aromatase inhibitor. A ...
News 47 results
https://www.medscape.com/viewarticle/968608
Feb 16th, 2022 - A number of clinical trials in breast cancer have opened in recent months. Maybe one of your patients could benefit from being enrolled. Menopausal women at moderate risk of developing breast cancer. A phase 2 study sponsored by the National Cance...
https://www.onclive.com/view/patient-case-frontline-treatment-options-for-her2-mbc
Feb 2nd, 2022 - Vijayakrishna Gadi, MD, PhD: We have a little more information on this patient. We find out from the breast biopsy that she’s got 1 of these HER2 [human epidermal growth factor receptor 2]–enriched phenotypes. She’s hormone receptor–negative for e...
https://www.onclive.com/view/dr-blanco-discusses-the-role-of-pathology-in-treatment-of-breast-cancer
Dec 20th, 2020 - Luis Z. Blanco Jr., MD, assistant professor of pathology, Northwestern University, discusses the role a pathologist plays in the treatment of a patient with breast cancer in an interview with OncLive during the Lynn Sage Breast Cancer Symposium. ...
https://www.mdedge.com/neurology/article/196674/business-medicine/will-patient-rewards-lower-cost-choices-impact-physicians?channel=39313
Gregory Twachtman
Mar 19th, 2019 - Patients will actively choose lower-cost options for certain health care services if their employers reward them for doing so. ThinkStock “In the first 12 months of the rewards program, we observed a 2.
https://www.staging.medscape.com/viewarticle/903385
Dec 5th, 2018 - Medscape Editor's Key Points: When receiving test results from other clinicians, be sure to review each line to avoid overlooking details. Place all reports and addenda in a patient's chart to maintain an ongoing record of care and to avoid missed...